Loading stock data…
Loading stock data…
US$0.40
Get one email when ELTP crosses your level. Checked every 15 minutes during market hours.
▲ +0.02 (6.43%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
61.9
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.00
Bullish momentumMACD above its signal line (0.00).
50-day average
0.36
Price aboveShort-term trend reference.
200-day average
0.45
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Drug Manufacturers - Specialty & Generic
Elite Pharmaceuticals Inc. is a specialty pharmaceutical company involved in the development and production of niche generic and innovative pharmaceutical products. The company's primary focus is on oral sustained and controlled release formulations, which play a crucial role in enhancing patient adherence and drug efficacy. By concentrating on the research and development of these niche products, Elite Pharmaceuticals provides solutions across a diverse range of therapeutic areas, including pai…
www.elitepharma.com| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-27 | 1.28 | 1.47 | ✓ Beat |
| 2026-03-20 | -0.18 | -0.15 | ✓ Beat |
| 2025-10-29 | 2.62 | 2.04 | ✗ Miss |
| 2022-06-28 | — | 0.01 | — |
| 2017-06-13 | — | -0.01 | — |
| 2008-02-13 | -0.3 | -0.15 | ✓ Beat |
| 2007-11-14 | -0.18 | -0.29 | ✗ Miss |
Companies in the same industry, via Finnhub